VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: Preclinical and phase I data by the Gynecologic Oncology Group Meeting Abstract
| Authors: | Monk, B. J.; Brady, W. E.; Lankes, H. A.; Facciabene, A.; Manjarrez, K.; Hershberg, R. M.; Fracasso, P. M.; Bell-McGuinn, K. M.; Walker, J. L.; McCourt, C. K.; Aghajanian, C.; Coukos, G. |
| Abstract Title: | VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: Preclinical and phase I data by the Gynecologic Oncology Group |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419601209 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.3077 |
| Notes: | Meeting Abstract: 3077 -- Source: Wos |
